Skip to content
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Dermatology · Ectodermal Dysplasia

How to Manage Dry Skin & Eyes in Ectodermal Dysplasia

At a Glance

Ectodermal dysplasia impairs moisture-producing glands, leading to chronic dry skin and severe dry eyes. Management requires aggressively replacing moisture by using thick, petroleum-based ointments daily on damp skin and applying preservative-free, lipid-based artificial tears for eye protection.

Because ectodermal dysplasia (ED) impairs the development of moisture-producing structures like sweat, sebaceous (oil), and mucous glands, managing chronic dry skin and dry eyes is a central part of daily life. Standard management focuses on aggressively substituting the moisture and protective oils the body cannot produce on its own. For extreme dry skin (xerosis) and eczema, dermatological protocols rely on the continuous application of heavy emollients and moisturizers to rebuild the skin’s barrier. For the eyes, the lack of oil-producing meibomian glands leads to rapid tear evaporation; management requires a combination of ophthalmological interventions like frequent, preservative-free artificial tears, warm compresses, and sometimes punctal plugs to prevent severe corneal damage.

Dermatological Care: Protecting the Skin Barrier

In many forms of ectodermal dysplasia, especially Hypohidrotic Ectodermal Dysplasia (HED), the skin lacks a normal concentration of sweat and oil glands [1]. This absence compromises the skin’s natural moisture barrier, leading to severe dry skin and an increased risk of eczema-like rashes [2][3].

Standard-of-care protocols for managing these skin symptoms include:

  • Heavy Emollients and the “Soak and Seal” Method: Because the skin cannot lubricate itself, aggressive and frequent application of heavy creams and ointments is required to trap moisture and restore the skin barrier [1][4]. Dermatologists often recommend applying thick, petroleum-based ointments or heavy ceramide creams immediately after a lukewarm shower while the skin is still damp (the “soak and seal” method). Thin, water-based lotions evaporate too quickly and will not adequately protect the skin barrier.
  • Targeted Eczema Therapies: When barrier breakdown leads to chronic eczema, standard topical treatments are often used. In certain stubborn cases, advanced systemic therapies like JAK inhibitors have shown effectiveness in managing severe skin manifestations [2][3]. These are powerful medications prescribed by specialists only after first-line treatments fail.
  • Syndrome-Specific Skin Care: It is important to tailor skincare to the specific type of ED. While HED primarily presents with extreme dryness, other conditions like AEC syndrome cause significant skin fragility and chronic scalp erosions that require specialized wound care protocols rather than basic moisturization [5][6].

Ophthalmological Care: Guarding Against Corneal Damage

The eyes rely on a delicate tear film to stay healthy. This film has a water layer (from lacrimal glands) and a protective oil layer. The oil layer is produced by meibomian glands along the edge of the eyelids. In patients with ED, these glands are often severely deficient, atrophied, or completely absent [7][8][9]. This is called meibomian gland dysfunction (MGD), which leads to rapid tear evaporation and severe dry eye disease [7][8]. Without proactive management, chronic dry eye can cause painful corneal scarring and ulceration [10].

To protect the ocular surface, an eye care specialist will typically recommend a multi-step approach:

  • Preservative-Free and Lipid-Based Artificial Tears: Continuous use of lubricating eye drops helps replace missing moisture. Because the primary issue is often a lack of oil, lipid-based (oil-containing) eye drops and thick nighttime eye ointments are especially useful for stabilizing the tear film [8]. It is critical to use preservative-free drops when applying them frequently (more than 4 times a day), as the preservatives found in many standard drops can cause severe irritation and further damage an already compromised cornea.
  • Warm Compresses and Eyelid Hygiene: In the general population, MGD is often treated with warm compresses, eyelid scrubs, and mechanical expression to unclog glands [11][12]. However, if meibomian glands are congenitally absent or highly underdeveloped in a patient with ED, these traditional methods may have limited efficacy [9][13].
  • Punctal Plugs: Tiny devices can be inserted into the tear ducts (puncta) to block tear drainage, keeping artificial and natural tears on the eye longer. While commonly used for water-deficient dry eye, they must be used cautiously in ED, as the primary issue is often tear evaporation rather than a lack of tear production [14][15].
  • Advanced Ocular Therapies: For those with severe complications (more common in EEC syndrome), interventions like surgery to correct eyelid abnormalities such as ectropion (the outward turning of the eyelid) can help protect the eye [16][17]. Investigative treatments like limbal stem cell therapies and topical immunosuppressive medications are also being explored or utilized to stabilize the ocular surface in severe cases [18][19].

Long-term management requires a coordinated, multidisciplinary care team, integrating dermatologists and ophthalmologists to adapt treatments as the patient’s needs change from childhood through adulthood [20][21].

Common questions in this guide

Why does ectodermal dysplasia cause severe dry skin and eyes?
Ectodermal dysplasia impairs the normal development of moisture-producing structures in the body, such as sweat, oil, and mucous glands. Without these natural lubricants, the skin loses its moisture barrier and the eyes lack the oil needed to keep tears from evaporating.
What is the best way to moisturize skin if I have ectodermal dysplasia?
Dermatologists strongly recommend the "soak and seal" method. This involves taking a lukewarm shower and immediately applying thick, heavy ointments or ceramide creams while the skin is still damp to lock in moisture. Thin, water-based lotions evaporate too quickly to be effective.
Why do doctors check my meibomian glands for dry eyes?
Meibomian glands are tiny structures along your eyelids that produce the protective oil layer for your tears. In ectodermal dysplasia, these glands are often underdeveloped or missing completely, which causes your tears to evaporate rapidly and leads to severe dry eye disease.
What kind of eye drops are best for dry eyes in ectodermal dysplasia?
Because people with ectodermal dysplasia often lack the oil layer in their tears, doctors usually recommend lipid-based (oil-containing) artificial tears. It is critical to choose preservative-free drops, especially if you use them more than four times a day, to prevent further eye irritation.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my specific type of ectodermal dysplasia, what heavy emollients do you recommend for daily barrier repair versus active eczema flare-ups?
  2. 2.Has a meibography been performed to determine if I have functioning meibomian glands, or if they are entirely absent?
  3. 3.Which specific over-the-counter eye drops contain the lipids I need to replace my missing oil layer?
  4. 4.Given my meibomian gland status, are warm compresses likely to help me, or should I rely entirely on lipid-replacing eye drops?
  5. 5.What early warning signs of corneal damage should I watch for, and how often should I have comprehensive eye exams?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    A recurrent missense mutation in the EDAR gene causes severe autosomal recessive hypohidrotic ectodermal dysplasia in two consanguineous Kashmiri families.

    Sadia , Foo JN, Khor CC, et al.

    The journal of gene medicine 2019; (21(9)):e3113 doi:10.1002/jgm.3113.

    PMID: 31310406
  2. 2

    Hypohidrotic Ectodermal Dysplasia with c.28delG Mutation in Ectodysplasin A Gene and Severe Atopic Dermatitis Treated Successfully with Tofacitinib.

    Li X, Wu X, Elston DM, et al.

    Acta dermato-venereologica 2021; (101(1)):adv00352 doi:10.2340/00015555-3693.

    PMID: 33196100
  3. 3

    An epidemiological survey of anhidrotic/hypohidrotic ectodermal dysplasia in Japan: High prevalence of allergic diseases.

    Inazawa-Terada M, Namiki T, Omigawa C, et al.

    The Journal of dermatology 2022; (49(4)):422-431 doi:10.1111/1346-8138.16278.

    PMID: 34897795
  4. 4

    A Splice Defect in the EDA Gene in Dogs with an X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Phenotype.

    Waluk DP, Zur G, Kaufmann R, et al.

    G3 (Bethesda, Md.) 2016; (6(9)):2949-54 doi:10.1534/g3.116.033225.

    PMID: 27449516
  5. 5

    Novel missense mutation of the TP63 gene in a newborn with Hay-Wells/Ankyloblepharon-Ectodermal defects-Cleft lip/palate (AEC) syndrome: clinical report and follow-up.

    Serra G, Antona V, Giuffré M, et al.

    Italian journal of pediatrics 2021; (47(1)):196 doi:10.1186/s13052-021-01152-y.

    PMID: 34583755
  6. 6

    Tooth defects of EEC and AEC syndrome caused by heterozygous TP63 mutations in three Chinese families and genotype-phenotype correlation analyses of TP63-related disorders.

    Zheng J, Liu H, Zhan Y, et al.

    Molecular genetics & genomic medicine 2019; (7(6)):e704 doi:10.1002/mgg3.704.

    PMID: 31050217
  7. 7

    Infrared meibography and molecular assessment of p63 gene mutations in a Mexican patient with EEC syndrome.

    Garza-Leon M, León-Cachón RBR, Villafuerte-de la Cruz R, Martínez-Treviño DA

    Archivos de la Sociedad Espanola de Oftalmologia 2018; (93(11)):562-566 doi:10.1016/j.oftal.2018.06.005.

    PMID: 30025988
  8. 8

    Hypohidrotic ectodermal dysplasia: a case report.

    Chandravanshi SL

    Orbit (Amsterdam, Netherlands) 2020; (39(4)):298-301 doi:10.1080/01676830.2019.1688358.

    PMID: 31694435
  9. 9

    The Role of Meibography in the Diagnosis of Meibomian Gland Dysfunction in Ocular Surface Diseases.

    Robin M, Liang H, Rabut G, et al.

    Translational vision science & technology 2019; (8(6)):6 doi:10.1167/tvst.8.6.6.

    PMID: 31737430
  10. 10

    Extended Overview of Ocular Phenotype with Recent Advances in Hypohidrotic Ectodermal Dysplasia.

    Callea M, Bignotti S, Semeraro F, et al.

    Children (Basel, Switzerland) 2022; (9(9)) doi:10.3390/children9091357.

    PMID: 36138666
  11. 11

    Mechanical meibomian gland squeezing combined with eyelid scrubs and warm compresses for the treatment of meibomian gland dysfunction.

    Lee H, Kim M, Park SY, et al.

    Clinical & experimental optometry 2017; (100(6)):598-602 doi:10.1111/cxo.12532.

    PMID: 28295626
  12. 12

    Chambered warm moist air eyelid warming devices - a review.

    Magno MS, Olafsson J, Beining M, et al.

    Acta ophthalmologica 2022; (100(5)):499-510 doi:10.1111/aos.15052.

    PMID: 34750979
  13. 13

    Histopathology and selective biomarker expression in human meibomian glands.

    Reneker LW, Irlmeier RT, Shui YB, et al.

    The British journal of ophthalmology 2020; (104(7)):999-1004 doi:10.1136/bjophthalmol-2019-314466.

    PMID: 31585964
  14. 14

    Meibomian gland dysfunction and primary Sjögren's syndrome dry eye: a protocol for systematic review and meta-analysis.

    Zi C, Huang Q, Ren Y, et al.

    BMJ open 2021; (11(12)):e048336 doi:10.1136/bmjopen-2020-048336.

    PMID: 35044322
  15. 15

    Prevalence of meibomian gland dysfunction at a tertiary centre in Taiwan.

    Chang YM, Weng TH, Chien CC, et al.

    Clinical & experimental optometry 2024; (107(5)):515-521 doi:10.1080/08164622.2023.2246129.

    PMID: 37766425
  16. 16

    Clinical features, surgical outcomes and genetic analysis of ectodermal dysplasia with ocular diseases.

    Chen X, Zeng WX, Duan BY, et al.

    International journal of ophthalmology 2022; (15(7)):1062-1070 doi:10.18240/ijo.2022.07.04.

    PMID: 35919316
  17. 17

    A spectrum of TP63-related disorders with eight affected individuals in five unrelated families.

    Soğukpınar M, Utine GE, Boduroğlu K, Şimşek-Kiper PÖ

    European journal of medical genetics 2024; (68()):104911 doi:10.1016/j.ejmg.2024.104911.

    PMID: 38281558
  18. 18

    Innovative Therapeutic Approaches for the Treatment of the Ocular Morbidities in Patients with EEC Syndrome.

    Barbaro V, Bonelli F, Ferrari S, et al.

    Cells 2023; (12(3)) doi:10.3390/cells12030495.

    PMID: 36766837
  19. 19

    Ectodermal Dysplasia: Association with Anti-Basement Membrane Autoantibodies.

    Lucero Saá F, Cremona FA, Mínguez NX, et al.

    Ocular immunology and inflammation 2020; (28(4)):703-707 doi:10.1080/09273948.2019.1609526.

    PMID: 31268817
  20. 20

    Dental Management of Ectodermal Dysplasia: A Report of Two Clinical Cases.

    Elgasmi FE, Rahmaoui M, Elarabi S, Badre B

    Cureus 2025; (17(5)):e84031 doi:10.7759/cureus.84031.

    PMID: 40510078
  21. 21

    Management of a patient with ectodermal dysplasia with implant-assisted and implant-supported restorations: Sixteen years of clinical care.

    Moustafa OH, Aldosari AM, Knobloch LA

    The Journal of prosthetic dentistry 2025; (134(6)):2035-2043 doi:10.1016/j.prosdent.2025.01.031.

    PMID: 39984407

This page provides educational information about managing skin and eye symptoms in ectodermal dysplasia. It is not a substitute for professional medical advice from your dermatologist or ophthalmologist.

Get notified when new evidence is published on Ectodermal dysplasia syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.